Description
Pharmacokinetics and Pharmacodynamics:
Favipiravir, the active ingredient in our range, exhibits potent antiviral activity by selectively inhibiting viral RNA-dependent RNA polymerase, a crucial enzyme for viral replication. This mechanism of action effectively suppresses viral replication and spread within the body, leading to a reduction in viral load and symptom relief. Pharmacokinetic studies have demonstrated rapid absorption following oral administration, with peak plasma concentrations achieved within hours. Favipiravir is metabolized in the liver and excreted primarily through the urine, with a half-life conducive to convenient dosing regimens.
Drug Classification:
Favipiravir belongs to the class of antiviral medications known as nucleoside analogs. It specifically targets RNA viruses, including influenza viruses and certain RNA viruses associated with emerging infectious diseases.
Formulations:
Our Favipiravir Range is available in tablet form, with each tablet containing 200 mg of Favipiravir.
Indications:
Treatment of influenza infections, including seasonal influenza and novel influenza strains.
Management of viral respiratory infections, including those caused by RNA viruses such as coronaviruses.
Usage:
Our Favipiravir Range is intended for oral administration and should be taken as directed by a healthcare professional. It is recommended to take the tablets with food to enhance absorption and minimize gastrointestinal side effects.
Dosage:
The recommended dosage of Favipiravir is based on the severity of the infection and the patient’s weight. Please consult your healthcare provider for personalized dosing instructions.
Side Effects:
While Favipiravir is generally well-tolerated, some patients may experience mild to moderate side effects, including:
- Gastrointestinal disturbances (nausea, vomiting, diarrhea)
- Headache
- Elevated liver enzymes (transaminases)
- Rash or skin reactions
These side effects are usually transient and resolve with continued treatment. However, if you experience any persistent or severe adverse reactions, please consult your healthcare provider immediately.
Packing Specifications:
Our Favipiravir Range is available in packs of 10 tablets, conveniently packaged for ease of use and storage.
At AIT Pharmaceuticals Division, we are committed to delivering innovative healthcare solutions that make a meaningful difference in the lives of patients worldwide. Trust in our Favipiravir Range to provide effective antiviral therapy with the quality and reliability you deserve.
Reviews
There are no reviews yet.